Back
G1 Therapeutics Vs. Amicus Therapeutics Industry Stock Comparison
Sell
41
GTHX
G1 Therapeutics
Last Price:
4.43
Seasonality Move:
16.06%
Sell
31
FOLD
Amicus Therapeutics
Last Price:
10.42
Seasonality Move:
19.73%
Sell
41
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy, Sell or Hold?
- The current G1 Therapeutics [GTHX] share price is $4.13. The Score for GTHX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- GTHX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $10.42. The Score for FOLD is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GTHX Stock Price Chart
What is G1 Therapeutics's stock price today?
-
The G1 Therapeutics share price today is $4.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTHX is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $10.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.
GTHX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 51.27 | Buy |
| Chaikin Money Flow: | 691024 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4 - 4.66) | Sell |
| Bollinger Bands (100): | (2.86 - 4.34) | Buy |
FOLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 40.54 | Sell |
| Chaikin Money Flow: | 1368197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.37 - 11.53) | Sell |
| Bollinger Bands (100): | (11.23 - 13.49) | Sell |
GTHX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.97 | Buy |
| 20-day SMA: | 4.28 | Sell |
| 50-day SMA: | 3.81 | Buy |
| 200-day SMA: | 2.64 | Buy |
| 8-day EMA: | 3.99 | Buy |
| 20-day EMA: | 4.09 | Buy |
| 50-day EMA: | 3.92 | Buy |
| 200-day EMA: | 3.38 | Buy |
FOLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.4 | Buy |
| 20-day SMA: | 10.78 | Sell |
| 50-day SMA: | 11.7 | Sell |
| 200-day SMA: | 12.17 | Sell |
| 8-day EMA: | 10.37 | Buy |
| 20-day EMA: | 10.73 | Sell |
| 50-day EMA: | 11.41 | Sell |
| 200-day EMA: | 11.97 | Sell |
G1 Therapeutics Earnings Growth & GTHX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $0.45 per share.
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.50 per share, and an increase next year of $0.38 per share.
G1 Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amicus Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||